Keith M. Gregg

Medicine · Health Sciences

14h-index2.6kcitations26works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(9), Dementia and Cognitive Impairment Research(6), Anesthesia and Sedative Agents(5), Statistical Methods in Clinical Trials(3), Anesthesia and Pain Management(2)

Publications26 total

Clinical Trials in Alzheimer’s Disease
Psychopharmacology Bulletin·2025
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer’s Disease
Journal of Alzheimer s Disease·2015· 58 cited
Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Neurology·2015· 149 citedOpen Access
Cognition in MCI and Alzheimer’s Disease: Baseline Data from a Longitudinal Study of the NTB
The Clinical Neuropsychologist·2014· 14 cited
O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers
Alzheimer s & Dementia·2013· 2 citedOpen Access
P1–356: Correlation of brain atrophy with clinical progression in mild‐to‐moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Alzheimer s & Dementia·2013· 1 cited
P1–352: The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Alzheimer s & Dementia·2013· 2 citedOpen Access
IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials
Alzheimer s & Dementia·2013Open Access
P4–417: Incidence and clinical progression of placebo‐treated amyloid‐negative subjects with mild‐to‐moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab
Alzheimer s & Dementia·2013· 11 cited
Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalities
Alzheimer s & Dementia·2013· 70 cited
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
The Lancet Neurology·2012· 497 citedOpen Access
P4‐227: Divergence of effect analysis (slope analysis) in disease‐modifying AD Trials
Alzheimer s & Dementia·2011
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
The Lancet Neurology·2010· 694 cited
The official scientific journal of the International Anesthesia Research Society ® , The Society of Cardiovascular Anesthesiologists, the Society for Pediatric Anesthesia, the Society for Ambulatory Anesthesia, the International Society for Anaesthetic Pharmacology, the Society for Technology in Anesthesia, the Anesthesia Patient Safety Foundation, the American Society of Critical Care Anesthesiologists, and the Society for Obstetric Anesthesia and Perinatology.
2008
Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics
Anesthesiology·2003· 160 citedOpen Access
Response Surface Model for Anesthetic Drug Interactions
Anesthesiology·2000· 352 citedOpen Access
A Technique for Population Pharmacodynamic Analysis of Concentration-Binary Response Data 
Anesthesiology·1997· 7 citedOpen Access
Preoperative Anxiety and Fear
Anesthesia & Analgesia·1996· 86 cited
Preoperative Anxiety and Fear
Anesthesia & Analgesia·1996· 76 cited
Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an α2-adrenoceptor agonist
European Journal of Pharmacology·1996· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Enchi Liu(10), Michael Grundman(9), Steven L. Shafer(8), Nick C. Fox(6), Bradley T. Wyman(6), Eric Yuen(6), Stephen Salloway(5), Yuan Lü(5), Peter Collins(5), Iulia Cristina Tudor(5), Robert Brashear(5), Reisa A. Sperling(4), Charles F. Minto(4), Thomas W. Schnider(4), Ronald S. Black(3), H. Robert Brashear(3), Mark E. Schmidt(3), Richard Margolin(3), Gerald Novak(3), Casper Nielsen(3)